Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab

Shalini Yalamanchi, Harry W. Flynn

Research output: Contribution to journalArticlepeer-review

1 Scopus citations

Abstract

A 39-year-old male with decreased visual acuity and extensive macular hemorrhage and edema secondary to a hemiretinal vein occlusion was treated with multiple intravitreal injections of bevacizumab 1.25 mg every four to six weeks for over one year. Treatment outcomes were assessed by visual acuity and Cirrus spectral domain optical coherence tomography. Treatment resulted in ongoing visual and anatomic improvement, with resolution at the last visit.

Original languageEnglish (US)
Pages (from-to)1509-1513
Number of pages5
JournalClinical Ophthalmology
Volume5
Issue number1
DOIs
StatePublished - Oct 14 2011

Keywords

  • Bevacizumab
  • Macular edema
  • Retinal vein occlusion

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Hemiretinal vein occlusion with macular hemorrhage and edema treated with intravitreal bevacizumab'. Together they form a unique fingerprint.

Cite this